Search for: "Level v. State" Results 1441 - 1460 of 29,813
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2023, 11:31 pm by INFORRM
The Community Court of Justice of the Economic Community of West African States SERAP v. [read post]
15 Sep 2023, 6:47 pm
But to be effective these ought to focus on targeted states rather than on the modalities of leading state self-actualization. [read post]
15 Sep 2023, 10:09 am by Carolina Guiral
Provide examples of factors that weigh in favor of approval when USCIS officers perform the two-part “final merits” analysis under Kazarian v. [read post]
15 Sep 2023, 4:00 am by Deanne Sowter
Case Commented On: Ahluwalia v Ahluwalia, 2022 ONSC 1303 (Can LII); 2023 ONCA 476 (CanLII) Intimate partner violence (IPV) takes many forms, all of which cause harm to survivors (who are disproportionately women and children). [read post]
13 Sep 2023, 11:46 am by LII Team
  At the state level, agencies in Massachusetts, Texas, California, Indiana, and Oklahamoa had the top referring websites, though the city of Charlotte, NC was also high on the list. [read post]
12 Sep 2023, 5:00 am by James Jolin
JRJ: What are some potential steps governments might take on the state or federal level to ensure that people who don’t have insurance coverage can still access this form of care? [read post]
11 Sep 2023, 1:13 pm by David Klein
Currently pending before the United States Supreme Court is the matter of Acheson Hotels, LLC v. [read post]
11 Sep 2023, 2:30 am by Felix Mikolasch
In line with its previous findings that damage is required for compensation, the Court states that a person affected needs to prove non-material damage (para. 50). [read post]
10 Sep 2023, 7:24 pm by Kurt R. Karst
  The final guidance contains a new addition that states that if there is an appropriate justification as to why a sponsor cannot submit patient-level data to FDA through traditional channels, third parties can provide these data through either a pre-IND or Type V Drug Master File (“DMF”) and provide the sponsor with a letter of authorization for FDA to reference the data. [read post]